Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Price:
4.1611
USD
5.34%
Market Cap:
$2.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
US |
|
MAG Interactive AB (publ)
F:MHK
|
SE |
|
J
|
Jinxin Technology Holding Co
NASDAQ:NAMI
|
CN |
|
Asseco Poland SA
F:SFB1
|
PL |
|
I
|
Inflection Point Acquisition Corp VI
NASDAQ:IPFX
|
US |
|
BriQ Properties REIC
F:BRW
|
GR |
|
Mobile Telecommunications Company Saudi Arabia SJSC
SAU:7030
|
SA |
|
A
|
Accor SA
SWB:ACR
|
FR |
|
C
|
CES Energy Solutions Corp
OTC:CESDF
|
CA |
|
C
|
Chibougamau Independent Mines Inc
F:CLL1
|
CA |
|
Verbio SE
OTC:VBVBF
|
DE |
|
F
|
FamiCord AG
F:V3V
|
DE |
|
Amarin Corporation PLC
F:EH3
|
IE |
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
KR |
|
T
|
Truscott Mining Corp Ltd
ASX:TRM
|
AU |
|
K
|
KSH Holdings Ltd
F:XEUA
|
SG |
|
ECS Botanics Holdings Ltd
F:F1J
|
AU |
|
Vusion SA
LSE:0OA4
|
FR |
|
Tohoku Electric Power Co Inc
F:TKT
|
JP |
|
Bee Vectoring Technologies International Inc
OTC:BEVVF
|
CA |
|
F
|
First Horizon Corp
DUS:FT2
|
US |
Wall St Price Targets
RXRX Price Forecast
Based on 8 analysts
Based on 8 analysts
+47% Upside
from
$4.1611
today
Recursion Pharmaceuticals Inc (RXRX)’s 12-month stock price forecast through October 2027 has a consensus target of $6.12, implying 47% upside. The forecast is based on price targets from 8 Wall Street analysts.
RXRX Analyst Rating
Based on 7 analysts
Based on 7 analysts
Analysts rate RXRX Buy, with 3 of 7 recommending Buy or Strong buy.
Recursion Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RXRX's stock price target?
Price Target
6.12
USD
6.12
USD
According to Wall Street analysts, the average 1-year price target for RXRX is 6.12 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Recursion Pharmaceuticals Inc?
Projected CAGR
20%
20%
Over the last 5 years, the compound annual growth rate for Revenue has been 80%. The projected CAGR for the next 3 years is 20%.
What is the Gross Profit forecast for Recursion Pharmaceuticals Inc?
Projected CAGR
218%
218%
The compound annual growth rate for Gross Profit over the next 2 years is 218%.